Madrigal Pharmaceuticals, Inc. (MDGL)

501.68 +5.80 (+1.17%) USD  |  NASDAQ  |  Jan 16, 16:00
501.64 -0.04 (-0.01%) After-Hours: 20:00
More

Madrigal Pharmaceuticals Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. --
Amgen, Inc. --
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. --